This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GWPH GW Pharmaceuticals (GWPH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About GW Pharmaceuticals Stock (NASDAQ:GWPH) 30 days 90 days 365 days Advanced Chart Get GW Pharmaceuticals alerts:Sign Up Key Stats Today's Range$218.96▼$218.9650-Day Range$216.90▼$219.2852-Week Range$87.07▼$219.57VolumeN/AAverage Volume899,771 shsMarket Capitalization$6.86 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.Read More… Receive GWPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GW Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address GWPH Stock News HeadlinesHere’s where things stand with GWU resident doctors, hospital nurses’ union contract negotiationsMay 29, 2024 | bizjournals.comMelaka: Malaysia’s 2.2-GW Cutting-Edge Combined Cycle Gas Power PlantOctober 14, 2023 | powermag.comTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgates for a $15 trillion crypto surge. My latest crypto playbook reveals the coin I’m most bullish on—including the name, ticker, and why I’m investing personal capital into it.May 28, 2025 | Paradigm Press (Ad)GWPRF Historical DataSeptember 28, 2023 | uk.investing.comGeorge Washington UniversityAugust 17, 2023 | usnews.comChina Approves 106 GW of New Coal-Fired CapacityMarch 9, 2023 | powermag.comWhy Nasdaq-Traded Marijuana Stocks Remain UndervaluedFebruary 19, 2023 | thestreet.comGW Pharmaceuticals PLC (GWPRF)September 25, 2022 | investing.comSee More Headlines GWPH Stock Analysis - Frequently Asked Questions How were GW Pharmaceuticals' earnings last quarter? GW Pharmaceuticals plc (NASDAQ:GWPH) posted its quarterly earnings data on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36) EPS for the quarter, topping analysts' consensus estimates of ($0.63) by $0.27. The firm's quarterly revenue was up 50.7% on a year-over-year basis. What other stocks do shareholders of GW Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that GW Pharmaceuticals investors own include NVIDIA (NVDA), Canopy Growth (CGC), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), Advanced Micro Devices (AMD) and Alibaba Group (BABA). Company Calendar Last Earnings11/03/2020Today5/27/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:GWPH CIK1351288 Webwww.gwpharm.com Phone44-12-2326-6800FaxN/AEmployees1,161Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$9.02 million Net Margins-11.05% Pretax MarginN/A Return on Equity-7.46% Return on Assets-6.13% Debt Debt-to-Equity Ratio0.01 Current Ratio5.13 Quick Ratio4.31 Sales & Book Value Annual Sales$311.33 million Price / Sales22.05 Cash Flow$0.01 per share Price / Cash Flow18,588.22 Book Value$23.48 per share Price / Book9.33Miscellaneous Outstanding Shares31,349,000Free FloatN/AMarket Cap$6.86 billion OptionableOptionable Beta2.15 Social Links 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:GWPH) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredThe “Miracle Metal” that saved 379 livesAccording to Airbus, it’s all thanks to a “miracle metal” built into the aircraft’s frame. This same materi...True Market Insiders | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GW Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GW Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.